Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Cancer Drug Targets, Volume 8 - Number 3



The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

, 8(3): 187 - 198

Amancio Carnero, Carmen Blanco-Aparicio, Oliver Renner, Wolfgang Link and Juan F.M. Leal


DOI: 10.2174/156800908784293659


Circulating Levels of VCAM and MMP-2 May Help Identify Patients with More Aggressive Prostate Cancer

, 8(3): 199 - 206

Concetta De Cicco, Laura Ravasi, Laura Zorzino, Maria Teresa Sandri, Edoardo Botteri, Fabrizio Verweij, Donatella Granchi, Ottavio de Cobelli and Giovanni Paganelli


DOI: 10.2174/156800908784293613


Deregulation of the Mitochondrial Apoptotic Machinery and Development of Molecular Targeted Drugs in Acute Myeloid Leukemia

, 8(3): 207 - 222

G. Del Poeta, A. Bruno, M. I. Del Principe, A. Venditti, L. Maurillo, F. Buccisano, R. Stasi, B. Neri, F. Luciano, A. Siniscalchi, P. de Fabritiis and S. Amadori


DOI: 10.2174/156800908784293640





Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75

Advertisement

CITATION BOOSTERNew Year Offer 2021

Related Journals

Related eBooks

eBooks Catalog